Document is current
Any future updates will be listed below
-
Authors
Parikh, Purvish
Babu, Govind
Singh, Randeep
Krishna, Vamshi
Bhatt, Amit
Bansal, Indu
Rajappa, Senthil
Sahoo, Tarini Prasad
Aggarwal, Shyam
Bapna, Ajay
Biswas, Ghanshyam
Somashekhar, SP
Bajpai, Jyoti
Maniar, Vashishtha
Desai, Sharad
Raja, T
Rath, Goura Kishor
- License Information
-
More Information
Article History
Received: 18 May 2022
Accepted: 28 June 2023
First Online: 31 July 2023
Declarations
:
: As the study involves a survey on obtaining consensus on adjuvant therapies in HR+/HER2 negative early breast cancer, ethics approval and informed consent is deemed unnecessary as per national legislation, DCGI (Drug Controller General of India).
: Not applicable.
: All other authors have no other competing interests to declare. All authors are practicing oncologists.
: The study does not involve any experimental protocols on human subjects. It uses a method that is well-adapted internationally for conducting a survey of this kind.
